Articles
Politics versus facts
1.9.2010 | Articles - biotech and pharmacy
The start of new technologies was never easy. From to-day bureaucratic vocabulary we can say that new achievements always met “precautionary principle”. This is a box available for whole set of wild catastrophic scenarios.
Slowing U.S. Economic Recovery & The Environmental Biotech Industry
25.8.2010 | Articles - biotech and pharmacy
In late July, Federal Reserve Chairman Ben Bernanke testified before Congress concerning monetary policy actions and the general economic recovery in the United States. In his testimony he stated the economic outlook in the U.S. is “unusually uncertain.” This very dovish outlook from the Federal Reserve caused a wave of risk aversion to...
Cellular armature against HIV
18.8.2010 | Articles - biotech and pharmacy
A group of Spanish scientists headed by Felix Goñi found out a new way how to decrease the number of HIV positive people in our population (Vieira et al., 2010). According to their study we could stop the process of the fusion of the cell and the HIV in a new way.
3rd invitation to participate in the program Czech Technology Accelerator
16.8.2010 | Newly on Gate2Biotech
CzechInvest announces CzechAccelerator, which aims to provide funding and strategic partnerships.
Enhanced CO2 fixation and biofuel production via microalgae
5.8.2010 | Newly on Gate2Biotech
Unbalanced production of atmospheric CO2 constitutes a major challenge to global sustainability. Technologies have thus been developed for enhanced biological carbon fixation (also referred to as CO2 mitigation), and one of the most promising capitalizes on microalgae.
Inherited clubfoot can be associated with chromosomal abnormality
20.7.2010 | Articles - biotech and pharmacy
Clubfoot is a relatively common congenital anomaly of the lower extremity. The etiology of this anomaly is believed to be multifactorial – so both exogenous and genetic factors can be involved. The recent study shows a possible connection of the inherited clubfoot form with structural chromosomal aberration on the chromosome 17...
Past, presence and future of the surveillance of the congenital anomalies
16.7.2010 | Articles - biotech and pharmacy
Congenital anomalies monitoring systems and surveillance programs were created in many countries during the 20th century. Their main goal was to identify potential teratogenic threats that may affect the general population. Today these organizations have many new duties that should decrease incidences of congenital anomalies in n...
Risk for hypertension for those who consume too much fructose
14.7.2010 | Newly on Gate2Biotech
American scientists found out, that with a daily consumption of 74 grams of fructose rises by 26 per cent the risk of exceeding the arterial blood pressure of 135/85 mmHg and by 77 per cent the risk of exceeding the pressure of 160/100 mmHg. Today the blood pressure is considered normal up to 140/90 mmHg.
New drug could improve the learning ability of individuals with Down syndrome
6.7.2010 | Articles - biotech and pharmacy
Researchers from Texas might be able to help the children with Down syndrom some day. They found out, that there may be a protein responsible for the impairment of cognitive functions. This protein belongs to amyloids, which are pathological protein aggregates with specific properties. Abnormal accumulation of amyloid leads to many diseases. In...
Legal ban of GM crops – discussion
22.6.2010 | GMO - NEWS
possible for Member States to ban the cultivation of GM crops on their territory. The process foresees two steps: first the adjustment of co-existence rules in a way that in fact prevent farmers growing GM crops; and second allowing legal bans. These new rules should accelerate the GM authorisation process.
- Search in databases:
- Organizations
- Projects
- Links
- Books
- Journals
- Legislative
- Events
